Sildenafil for treating patients with COVID-19 and perfusion mismatch: a pilot randomized trial
Abstract
Background: SARS-CoV-2 seems to affect the regulation of pulmonary perfusion. Hypoperfusion in areas of well-aerated lung parenchyma results in a ventilation-perfusion mismatch that can be characterized using subtraction computed tomography angiography (sCTA). This study aims to evaluate the efficacy of oral sildenafil in treating COVID-19 inpatients showing perfusion abnormalities in sCTA.
Más información
| Título según WOS: | Sildenafil for treating patients with COVID-19 and perfusion mismatch: a pilot randomized trial |
| Título de la Revista: | CRITICAL CARE |
| Volumen: | 26 |
| Número: | 1 |
| Editorial: | LONDON |
| Fecha de publicación: | 2022 |
| DOI: |
10.1186/S13054-021-03885-Y |
| Notas: | ISI |